Page last updated: 2024-12-11

16-methylprogesterone, (16alpha)-isomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

## 16-methylprogesterone (16α-isomer) - A Research Focus

16-methylprogesterone, specifically the (16α)-isomer, is a synthetic steroid hormone that is structurally similar to progesterone. It's important for research due to its unique properties and potential applications in various fields.

**Key Features and Potential Uses:**

* **Anti-inflammatory and Immunosuppressive Effects:** 16-methylprogesterone exhibits potent anti-inflammatory and immunosuppressive properties. This makes it a potential therapeutic agent for conditions like autoimmune diseases (e.g., rheumatoid arthritis, lupus), inflammatory bowel disease, and transplant rejection.
* **Neuroprotective Effects:** Studies have shown that 16-methylprogesterone can protect neurons from damage caused by various stressors, including stroke, traumatic brain injury, and neurodegenerative diseases like Alzheimer's and Parkinson's. This makes it an intriguing candidate for treating these debilitating conditions.
* **Hormonal Regulation:** 16-methylprogesterone possesses weaker progestational activity compared to progesterone, but it can still modulate hormonal pathways. This makes it a potential tool for studying and manipulating the endocrine system, especially in contexts related to fertility, contraception, and hormone-sensitive cancers.
* **Anti-cancer Properties:** 16-methylprogesterone has demonstrated anti-cancer activity in certain cell lines and animal models. Its mechanism of action likely involves inhibiting cell proliferation and promoting apoptosis in cancer cells. This opens up the possibility for its use in cancer therapies, particularly for hormone-sensitive cancers.
* **Neurosteroid Properties:** 16-methylprogesterone can be synthesized in the brain, making it a neurosteroid. This adds another layer of complexity to its potential roles in neurological function and behavior.

**Importance for Research:**

The unique properties of 16-methylprogesterone (16α-isomer) make it a valuable tool for researchers in various fields, including:

* **Pharmacology:** Understanding its mechanisms of action and potential therapeutic applications in diverse diseases.
* **Endocrinology:** Studying its role in hormonal regulation and its potential for manipulating endocrine pathways.
* **Neurology:** Investigating its neuroprotective effects and potential for treating neurological disorders.
* **Oncology:** Examining its anti-cancer properties and its potential for developing new cancer therapies.

**Research Challenges and Future Directions:**

While promising, research on 16-methylprogesterone is still in its early stages. There are several challenges that need to be addressed before it can be widely applied clinically:

* **Pharmacokinetics and Metabolism:** Understanding its absorption, distribution, metabolism, and excretion in the body is crucial for optimizing its therapeutic potential.
* **Safety and Toxicity:** Extensive studies are required to assess its safety and potential side effects in humans.
* **Drug Delivery:** Developing effective and safe delivery methods for 16-methylprogesterone is essential for achieving optimal therapeutic outcomes.

Overall, 16-methylprogesterone (16α-isomer) holds significant promise for research and the development of novel therapies for a wide range of conditions. Continued research is essential to fully understand its potential and overcome the challenges associated with its clinical application.

Cross-References

ID SourceID
PubMed CID9862261
CHEMBL ID2311119
SCHEMBL ID601152
MeSH IDM0320373

Synonyms (17)

Synonym
1239-79-8
SCHEMBL601152
CHEMBL2311119
16a-methyl-4-pregnene-3,20-dione
16-a-methylprogesterone
16.alpha.-methylprogesterone
JYYRDDFNMDZIIP-SMWISZJMSA-N
progesterone, 16.alpha.-methyl-
pregn-4-ene-3,20-dione, 16-methyl-, (16.alpha.)-
16.alpha.-methylpregn-4-ene-3,20-dione
pregn-4-ene-3,20-dione, 16.alpha.-methyl-
16amethylprogesterone
DTXSID60432040
4-pregnen-16|-methyl-3,20-dione
(8s,9s,10r,13s,14s,16r,17s)-17-acetyl-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3(2h)-one
(8s,9s,10r,13s,14s,16r,17s)-17-acetyl-10,13,16-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
pregn-4-ene-3,20-dione, 16alpha-methyl-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID51053Compound was evaluated for its binding affinity towards the human corticosteroid binding globulin1999Journal of medicinal chemistry, Feb-25, Volume: 42, Issue:4
Self-organizing molecular field analysis: a tool for structure-activity studies.
AID213396Glucocorticoid induced Tyrosine Aminotransferase activity relative to Dexamethasone1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
AID51058Binding affinity towards corticosteroid-binding globulin (CBG)2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
AID51059Binding affinity to corticosteroid binding globulin1998Journal of medicinal chemistry, Jul-02, Volume: 41, Issue:14
Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices.
AID74376Relative binding affinity to glucocorticoid receptor on cytosol from liver at 4 hr1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
AID74374Relative binding affinity to glucocorticoid receptor on cytosol from hepatoma tissue cells at 4 hr1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
AID74377Relative binding affinity to glucocorticoid receptor on cytosol from thymus at 24 hr1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
AID162613Relative binding affinity for progestin receptor of uterus of rabbit at 24 hr1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
AID39320Relative binding affinity for androgen receptor of prostate of rat at 2 hr1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
AID51052In silico binding affinity to corticosteroid binding globulin (CBG)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations.
AID126435Relative binding affinity for mineralocorticoid receptor of rat kidney at 24 hr1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
AID74375Relative binding affinity to glucocorticoid receptor on cytosol from liver at 24 hr1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
AID74373Relative binding affinity to glucocorticoid receptor on cytosol from hepatoma tissue cells at 24 hr1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
AID74378Relative binding affinity to glucocorticoid receptor on cytosol from thymus at 4 hr1988Journal of medicinal chemistry, Jun, Volume: 31, Issue:6
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.80 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]